| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 11.321 | 27.061 | 38.063 | 41.866 | 32.918 | 42.000 | 31.702 | 2.273 | 0 |
| Total Income - EUR | - | 11.396 | 28.579 | 41.213 | 41.866 | 34.589 | 42.000 | 31.703 | 2.273 | 0 |
| Total Expenses - EUR | - | 10.875 | 28.399 | 29.000 | 21.048 | 32.777 | 32.085 | 35.120 | 7.216 | 2.764 |
| Gross Profit/Loss - EUR | - | 521 | 180 | 12.213 | 20.818 | 1.812 | 9.916 | -3.418 | -4.943 | -2.764 |
| Net Profit/Loss - EUR | - | 179 | -232 | 11.836 | 20.399 | 1.596 | 9.396 | -3.729 | -4.943 | -2.764 |
| Employees | - | 2 | 3 | 3 | 1 | 1 | 1 | 2 | 1 | 0 |
Check the financial reports for the company - Vlamedico Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 4.348 | 8.231 | 6.886 | 5.600 | 13.786 | 11.170 | 8.886 | 8.059 | 5.684 |
| Current Assets | - | 12.169 | 13.036 | 21.675 | 27.299 | 9.478 | 21.083 | 7.913 | 4.805 | 3.356 |
| Inventories | - | 10.943 | 9.912 | 8.890 | 9.005 | 220 | 0 | 0 | 286 | 2.294 |
| Receivables | - | 1.076 | 1.908 | 1.037 | 2.170 | 2.307 | 2.123 | 5.538 | 1.129 | 4 |
| Cash | - | 151 | 1.216 | 11.748 | 16.124 | 6.952 | 18.960 | 2.376 | 3.390 | 1.058 |
| Shareholders Funds | - | 224 | -46 | 11.714 | 31.840 | 21.051 | 29.980 | 14.178 | 9.147 | 5.519 |
| Social Capital | - | 45 | 44 | 43 | 42 | 43 | 42 | 43 | 42 | 42 |
| Debts | - | 16.294 | 21.313 | 16.847 | 1.059 | 2.213 | 2.273 | 2.622 | 3.718 | 3.522 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Vlamedico Srl